Medication info
Dapagliflozin 10mg (Dapagliflozin Propanediol Hydrate)

Dapagliflozin 10mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
VIVA KOREA Co., Ltd.
Appearance
Yellow, double-convex, diamond-shaped film-coated tablet
Packaging
30 tablets/PPT [10 tablets/PPT × 3]
Approval status
Active

MFDS item code 202300330 · Approved 2023.01.25 · Insurance code 658204710

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of pharmacological treatment for diabetes, when this medicine is administered in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
VIVA KOREA Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes, along with dietary and exercise therapy. It can be used alone or in combination with other medications and is particularly beneficial for patients whose blood sugar is not well controlled. It is also indicated for patients with cardiovascular diseases and risk factors. This medication plays an important role in diabetes management by improving blood sugar levels. Overall, it is effectively used for the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of pharmacological treatment for diabetes, when this medicine is administered in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablets should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who are allergic to its active ingredients or excipients. Do not administer this medication to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains lactose and should not be used in patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. This medication should not be administered to patients undergoing dialysis. Caution is required when using this medication in patients with reduced fluid volume or impaired renal function. This medication can cause a decrease in blood pressure or intravascular blood volume, and caution is especially needed in elderly patients with impaired renal function or those taking diuretics. Fluid volume and renal function should be evaluated before administration, and symptoms of hypotension and renal function should be continuously monitored after administration. In patients with moderate to severe renal impairment, the blood sugar control effect of this medication may be reduced, so caution is necessary. When using this medication, symptoms like genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur, so symptoms should be monitored carefully. Genital infections may be more common in women and patients with a history of such conditions. The risk of hypoglycemia may increase when used in conjunction with blood glucose-lowering agents like insulin or sulfonylureas, necessitating dosage adjustments. This medication may induce dehydration or hypotension due to decreased fluid volume; therefore, patients with unstable fluid status should consider discontinuation of treatment. Diabetic ketoacidosis may occur even if blood sugar levels are not high, so immediate examination and treatment are required when related symptoms are present. Severe urinary infections such as urinary tract infections and pyelonephritis have also been reported, so prompt treatment is needed if infection symptoms appear. In case of severe infection symptoms like necrotizing fasciitis, administration of the medication should be immediately stopped and appropriate treatment should be sought. Elderly patients should be managed more carefully due to the higher risk of renal function decline and decreased fluid volume. Pregnant women should not use this medication, and if pregnancy is confirmed, treatment should be discontinued immediately. Breastfeeding women are also advised against using this medication. Safety and efficacy in children and adolescents have not been adequately established, so there is no dosage for these age groups. In case of overdose, there is no specific antidote; appropriate treatment should be administered according to symptoms, and there is no research on whether this medication can be removed by dialysis. This medication does not significantly affect the ability to drive or operate machinery, but caution is required when taken with insulin or sulfonylureas due to the risk of hypoglycemia. This medication should be stored in its original container and kept out of the reach of children.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased initial renal creatinine clearance, dyslipidemia, increased initial blood creatinine, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicidal attempt, adenocarcinoma of the stomach, anaphylactic reaction, hyperglycemia, paresthesia, cerebral infarction, nerve compression, uroseptic shock, acute kidney injury, renal dysfunction, chest pain, chest discomfort, edema, facial edema, facial pain, warmth, flu-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormal eczema, nummular eczema, eczema, keratosis, nail pigmentation, skin lesions, urticaria, cold sweat, myofibrillar, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, flank pain, muscular weakness, myalgia, osteoarthritis, ligament sprain, dry eye, ocular pain, retinal disorders, vision impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicosity, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, enuresis, insomnia, fatty liver, gallbladder polyp, dizziness, tinnitus, vaginal discharge, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, urinary abnormalities, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, hypersthesia, taste abnormality, nasopharyngitis, upper respiratory infection, asthenia, hunger, vaginal discharge, itching

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be safely maintained.

Appearance and packaging

Appearance

Yellow, double-convex, diamond-shaped film-coated tablet

Package unit

30 tablets/PPT [10 tablets/PPT × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.